{
  "trial_id": "NCT00363129",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, ECOG Performance Status, type of cancer, chemotherapy regimen, life expectancy, ability to complete questionnaires, history of coronary artery disease, history of peripheral neuropathy, concurrent medications, history of diabetes, history of head or neck cancers, history of hemorrhagic stroke, use of vitamin E supplementation, use of anticoagulant medication.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Type of cancer",
          "type of cancer"
        ],
        [
          "Type of chemotherapy",
          "chemotherapy regimen"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race (NIH/OMB)",
        "Region of Enrollment",
        "Planned number of chemotherapy cycles"
      ],
      "remaining_candidate_features": [
        "ECOG Performance Status",
        "life expectancy",
        "ability to complete questionnaires",
        "history of coronary artery disease",
        "history of peripheral neuropathy",
        "concurrent medications",
        "history of diabetes",
        "history of head or neck cancers",
        "history of hemorrhagic stroke",
        "use of vitamin E supplementation",
        "use of anticoagulant medication"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Type of Cancer, Chemotherapy Regimen, Baseline Neuropathy Status, Concomitant Medications, Life Expectancy,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Type of cancer",
          "Type of Cancer"
        ],
        [
          "Type of chemotherapy",
          "Chemotherapy Regimen"
        ]
      ],
      "remaining_reference_features": [
        "Planned number of chemotherapy cycles"
      ],
      "remaining_candidate_features": [
        "ECOG Performance Status",
        "Baseline Neuropathy Status",
        "Concomitant Medications",
        "Life Expectancy"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Cancer Diagnosis, Chemotherapy Regimen, Prior Neurotoxic Chemotherapy, History of Peripheral Neuropathy, Diabetes Status, Vitamin E Supplementation.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Type of cancer",
          "Cancer Diagnosis"
        ],
        [
          "Type of chemotherapy",
          "Chemotherapy Regimen"
        ]
      ],
      "remaining_reference_features": [
        "Planned number of chemotherapy cycles"
      ],
      "remaining_candidate_features": [
        "ECOG Performance Status",
        "Prior Neurotoxic Chemotherapy",
        "History of Peripheral Neuropathy",
        "Diabetes Status",
        "Vitamin E Supplementation."
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, ECOG Performance Status, cancer type, chemotherapy regimen, prior chemotherapy exposure, comorbidities (e.g., diabetes, coronary artery disease), history of peripheral neuropathy, opioid use, anticonvulsant use, antidepressant use, vitamin E supplementation, smoking status, alcohol use.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Type of cancer",
          "cancer type"
        ],
        [
          "Type of chemotherapy",
          "chemotherapy regimen"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment",
        "Planned number of chemotherapy cycles"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "ECOG Performance Status",
        "prior chemotherapy exposure",
        "comorbidities (e.g., diabetes, coronary artery disease)",
        "history of peripheral neuropathy",
        "opioid use",
        "anticonvulsant use",
        "antidepressant use",
        "vitamin E supplementation",
        "smoking status",
        "alcohol use."
      ]
    }
  }
}